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Abstract
Background: The prognostic value of point-of-care lung ultrasound has not been evaluated in a large cohort of patients with
COVID-19 admitted to general medicine ward in the United States. The aim of this study was to describe lung ultrasound findings
and their prognostic value in patients with COVID-19 admitted to internal medicine ward. Method: This prospective observational study consecutively enrolled 105 hospitalized participants with COVID-19 at 2 tertiary care centers. Ultrasound was
performed in 12 lung zones within 24 hours of admission. Findings were assessed relative to 4 outcomes: intensive care unit (ICU)
need, need for intensive respiratory support, length of stay, and death. Results: We detected abnormalities in 92% (97/105) of
participants. The common findings were confluent B-lines (92%), non-homogenous pleural lines (78%), and consolidations (54%).
Large confluent B-lines, consolidations, bilateral involvement, and any abnormality in  6 areas were associated with a longer
hospitalization and need for intensive respiratory support. Large confluent B-lines and bilateral involvement were also associated
with ICU stay. A total lung ultrasound score <5 had a negative predictive value of 100% for the need of intensive respiratory
support. A higher total lung ultrasound score was associated with ICU need (median total 18 in the ICU group vs. 11 non-ICU,
p ¼ 0.004), a hospitalization  9d (15 vs 10, p ¼ 0.016) and need for intensive respiratory support (18 vs. 8.5, P < 0.001).
Conclusions: Most patients hospitalized with COVID-19 had lung ultrasound abnormalities on admission and a higher lung
ultrasound score was associated with worse clinical outcomes except death. A low total lung ultrasound score (<5) had a negative
predictive value of 100% for the need of intensive respiratory support. Point-of-care ultrasound can aid in the risk stratification for
patients with COVID-19 admitted to general wards.
Keywords
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Introduction
The number of patients infected with severe acute respiratory
syndrome-coronavirus-2 (SARS-CoV-2) continues to increase
in the United States and globally. Initial reports from China
reported that approximately 14% with coronavirus disease
2019 (COVID-19) developed severe illness requiring hospitalization, and 5% developed critical illness.1 Among hospitalized patients with COVID-19, the primary manifestation is
viral pneumonia,2 and among those with pneumonia, 20-42%
have developed acute respiratory distress syndrome (ARDS).3
Multiple diagnostic tools exist for diagnosing pneumonia.
Computed tomography (CT) of the chest is a sensitive imaging
modality to diagnose COVID-19 and monitor disease progression.4-6 COVID-19 pneumonia imaging typically shows bilateral multilobar ground-glass opacities with a peripheral or
posterior distribution.7 Lesions may progress to consolidative
opacities as the pneumonia progresses.7 Despite the utility of
CT, its use as a diagnostic modality is limited by multiple
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factors including the need for transport of infectious or unstable
patients and need for disinfection of radiology facilities afterward. In addition, CT may not be readily available in rural
health centers or other resource-limited settings. An alternative
radiologic technique is point-of-care ultrasound (POCUS) of
the lung for the diagnosis and monitoring of patients with
COVID-19.8,9 Lung ultrasound is a suitable imaging modality
in COVID-19 pneumonia as the lung lesions are predominantly
peripheral. Previous studies have shown lung ultrasound can
aid COVID-19 diagnosis.10-13
Most studies on ultrasound in patients with COVID-19
involved small cohorts. Larger studies on the use of ultrasound
in the emergency department,14,15 pulmonary service,16 and
medical ward, or intensive care17 indicated that lung ultrasound
findings early in the diagnosis were associated with worse
clinical outcomes. No large study has been performed in
patients with COVID-19 admitted to general medicine ward
in the United States, and none has attempted to demonstrate
predictive ability of ultrasound findings. The present study was
performed to determine the prognostic value of findings at the
time of hospital admission in a prospective cohort of consecutive COVID-19 patients.

Methods
Study Design, Setting, and Population
We conducted a prospective observational cohort study at 2
tertiary care hospitals, MedStar Georgetown University Hospital (MGUH) and MedStar Washington Hospital Center
(MWHC), in Washington DC. Over a 3-week period during
the peak of the first wave of infections in our region (April
18 to May 9, 2020 at MWHC and from 21 to May 10, 2020 at
MGUH), we screened adults aged  18 years for study eligibility who were admitted to a hospital medicine service.
Patients were included if they had a positive polymerase chain
reaction (PCR) for SARS-CoV-2 and were approached within
24 hours of admission. During the study period, patients generally had PCR results within 4 hours of collection. Patients
were excluded if they were unable to provide consent, were
unable to consent in English, pregnant, or had known structural
lung abnormalities. We collected demographics, comorbidities,
presenting symptoms, laboratory data, radiologic information,
and outcomes during the hospitalization. Written informed
consent was obtained from each participant. This study was
approved by the MedStar Research Institutional Review
Board(IRB ID: STUDY00002254).

Point-of-Care Lung Ultrasound Examination
An M-Turbo ultrasound machine and a 1- to 5-MHz phased
array probe (FUJIFILM SonoSite, Bothell, WA) were used for
the majority of the examinations (86 patients). SonoSite Edge
II with a 1- to 5- MHz phased array probe (FUJIFILM SonoSite, Bothell, WA) and Philips Lumify with a 1- to 4-MHz
phased array probe (Philips, Reedsville, PA) were used for
15 patients and 4 patients, respectively. Lung ultrasound was
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performed in 12 zones (Figure 1).18-20 Each intercostal space
of upper and lower parts of the anterior, lateral, and posterior
regions of the right and left chest wall was examined. Within
each region, the worst ultrasound finding detected was considered as characterizing the region. The duration of each ultrasound examination was approximately 10-15 minutes.
Ultrasound probe and machine were cleaned with recommended disinfectant before and after each use.
Ultrasounds were performed by authors EF and KY at
MGUH and MWHC, respectively. Both scanners have the
Society of Hospital Medicine/American College of Chest Physicians POCUS Certificate of Completion and teach POCUS
locally and nationally. Additionally, KY successfully completed the Examination of Special Competence in Critical Care
Echocardiography of the National Board of Echocardiography
(NBE). TM instructs nationally and internationally and director
of several courses. TM also has completed the Examination of
Special Competence in Adult Echocardiography by the NBE.

Lung Ultrasound Score and Findings
Each lung zone was evaluated for the following findings, and
listed by presumed increasing severity:
B line spectrum abnormalities




pathologic B lines ( 3 well-defined B lines)
confluent B line(s), small (<1 cm) and large (>1 cm)
white lung (any increased echogenicity below the
pleural line, covering the entire rib space and persisting during the entire respiratory cycle)

Pleural line spectrum abnormalities



non-homogenous pleural line
consolidation, small (< 1 cm) “subpleural” or large
(> 1 cm in any dimension)

For the lung ultrasound score, 0-3 points were allocated to
each zone (Figure 1) according to the following:
0 - the presence of lung sliding with A-lines or fewer than
2 well-defined B lines
1 -  3 well-defined B-lines
2 - confluent B-line(s), large or small, white lung with, or
small (< 1 cm) consolidation
3 - consolidation >1 cm.
A total lung ultrasound score was calculated as the sum of
scores for each of the 12 zones, with a possible range of 0
to 36.

Patient Outcomes
The following clinical outcomes were recorded for each
enrolled patient: intensive care unit (ICU) stay, the overall
length of stay, and death from any cause. An additional composite outcome of “intensive respiratory support” included those
requiring high-flow nasal cannula, non-rebreather, or
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Figure 1. Lung ultrasound zones and scoring. A and B, Zones of lung ultrasound. PSL parasternal line, AAL anterior axillary line, PAL posterior
axillary line, PVL paravertebral line. Examples of lung ultrasound findings according to lung ultrasound point. C, Normal aeration of the lung.
D, Three well differentiated B-lines, E, Confluent B-line, F, > 1 cm consolidation.

mechanical ventilation. We planned to compare the frequencies
of lung ultrasound scores by zone, the total lung ultrasound
score, and the individual findings (i.e., small confluence, large
consolidation) to each of these clinical outcomes to determine if
any were over-represented. Additionally, we wanted to see if the
lung ultrasound scores or individual findings had any power in
predicting outcomes.

Lung Scoring
Each lung ultrasound clip was scored independently by EF and
KY. Then all 1260 images were reviewed again jointly by EF,
TM, and KY, regardless of agreement, to arrive at a final
consensus description and score for each clip.

Statistical Analyses
Lung zone ultrasound findings and scores were compared by
outcome with the chi-square test, Fisher’s exact test, and
Kruskal-Wallis test, as appropriate with SAS software (SAS
Institute Inc., Cary, NC). Other analyses were conducted in R.21
Agreement between the raters was evaluated with Cohen’s
Kappa coefficient via the “vcd” package before calculating
final scores.22 The LOS was compared to a lung ultrasound
score made dichotomous (using 66% cutpoint) and using survival analysis with logrank testing.23

Logistic regression models were built to predict patients’
outcomes based on ultrasound findings or scores. Model operating characteristics were calculated using the ROCR package.24 A priori 70% of the data was selected to train models,
with the remaining 30% used for testing. Models were refined,
excluding zones or findings that did not contribute to the outcome prediction (based on the regression coefficient having a
p-value <0.1) to improve the prediction. The same 70% and
30% subsets were used for all derivations. Sensitivity and specificity are based on the predictions of the model on the test set
alone. Positive and negative predictive values were based on
the model performance on all patients. No data were censored.
Tests were performed at a significance level of 0.05 except for
the logistic regression model derivation for which we used a
more stringent level of 0.01 for significance.

Results
Participant Characteristics
During the study period, 229 patients with COVID-19 (171 at
MWHC and 58 at MGUH) were admitted to the hospital
medicine services at MWHC and MGUH. We enrolled 113
participants. Informed consent could not be provided by 59
non-English speakers, 49 were unable to consent 3 declined
to consent, 1 was a prisoner and 4 had exclusion criteria (1 pregnancy, 3 structural lung disease). Of the 113 enrolled, 105
participants underwent a LU within 24 hours of admission.
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Table 1. Demographic and Clinical Features of Patients With COVID-19 at Time of Hospital Admission Associated With Need for Intensive
Respiratory Support During the Hospitalization.

Characteristic
Age, years
Men
Race
Black
Hispanic
White
Asian
Comorbidities
Hypertension
Obesity (BMI  30)
Diabetes mellitus
End-stage renal disease
Congestive heart failure
Cancer
Asthma
Chronic obstructive lung disease
Symptoms
Days since symptom onset
Dyspnea
Cough
Fever
Asymptomatic
Body Mass index kg/m2
Oxygen saturation on room air
Initial laboratory measures
White blood cells, x 109 /L
Lymphocyte count, k/uL
D-dimer, mcg/mL
Ferritin, ng/mL
C-reactive protein, mg/L
Lactate dehydrogenase, u/L
Creatine kinase U/L
Troponin, abnormal
ESR >85 mm/hr
Treatment
Convalescent plasma therapy
Tocilizumab
Outcome
Intensive care
Mechanical ventilation
Death

Requiring intensive
respiratory support
(N ¼ 33)

All patients
(N ¼ 105)

No intensive
respiratory support
(N ¼ 72)

57 (48, 68)
65 (62)

56 (48, 64)
43 (60)

62 (48, 72)
22 (67)

65 (62)
34 (32)
5 (5)
1 (1)

45 (63)
22 (31)
4 (6)
1 (1)

20
12
1
0

(61)
(36)
(3)
(0)

62 (59)
52 (50)
30 (29)
12 (11)
7 (7)
7 (7)
6 (6)
2 (2)

48 (67)
34 (47)
19 (26)
7 (10)
4 (6)
5 (7)
5 (7)
1 (1)

14
18
11
5
3
2
1
1

(42)
(55)
(33)
(15)
(9)
(6)
(3)
(3)

6 (4 - 8)
76 (72)
76 (72)
62 (59)
7 (7)
29.8 (26.7, 34)
93 (90, 97)

7 (4-8)
50 (69)
51 (71)
40 (56)
7 (10)
29.4 (26.4, 34.2)
95 (92, 97)

5 (4–8)
26 (79)
25 (76)
22 (67)
0 (0)
30.7 (27, 33.6)
91 (88, 93)

6.4 (4.5, 8.1)
1200 (800, 1600)
0.98 (0.52, 1.92)
561 (247, 1185)
74 (22, 152)
360 (266, 469)
164 (83, 334)
24 (23)
29 (28)

5.9 (4.5, 7.6)
1250 (900, 1600)
0.8 (0.45, 1.65)
361 (238, 1082)
57 (14, 107)
298 (256, 414)
136 (73, 306)
13 (18)
17 (24)

7.2 (4.7, 8.4)
900 (600, 1300)
1.4 (0.87, 2.9)
940 (561, 1756)
156 (67, 183)
418 (342, 541)
194 (137, 680)
11 (33)
12 (36)

13 (12)
5 (5)

1 (1)
0

12 (36)
5 (15)

25
13 (12)
9 (9)

0 (0)
0 (0)
0 (0)

25 (76)
13 (39)
9 (27)

Values are N (%) or median (IQR). Intensive respiratory support defined as requiring high flow oxygen via nasal cannula, non-rebreather mask, or mechanical
ventilation during admission. Of note all deaths occurred in the intensive respiratory support group.

LU could not be completed within 24 hours of admission in
8 patients due to: transfer of care (1), significant dyspnea (1), or
sonographer’s clinical duties (6). The enrollment is summarized in Supplemental Figure 1.
The demographic and clinical characteristics of the enrolled
participants are provided in Table 1. The median age was
57 years (Interquartile range [IQR], 48 to 68), 65 patients
(62%) were male, 65% were black, and 34% were Hispanic.
Overall, 62 (59%) had hypertension, and 30 (29%) had diabetes

mellitus. Obesity was common (52%), and the median BMI
was 29.8 (IQR, 26.7 to 34) kg/m.2 The median days since the
symptom onset was 6 (IQR, 4 to 8). The most common presenting
symptoms were dyspnea (76%), cough (76%), and fever (62%).
During the study period, remdesivir or steroid therapy were not
utilized; however, 13 (12%) participants received convalescent
plasma therapy, and 5 (5%) received tocilizumab.
Of the 105 participants, 7 (6.6%) were asymptomatic
(admitted for other problems, remained on room air, and did

338

Journal of Intensive Care Medicine 36(3)

Figure 2. Boxplots of the total lung ultrasound score: (1) Asymptomatic or non-intensive respiratory support vs. intensive respiratory support
(top left), (2) Length of stay less than 9 days vs. greater than/equal 9 days (top right), (3) No ICU vs. ICU (down left), and (4) Alive vs. death
(down right).

not have fever, cough, dyspnea, or other COVID-19 related
symptoms), 65 (62%) were symptomatic but did not require
IRS and 33 (31%) required IRS, 25 (24%) required intensive
care, 13 (12%) required mechanical ventilation, and 9 (8.6%)
died during the hospitalization.
Lung ultrasound findings. A total of 1260 lung ultrasound images
were collected from the 105 participants, 12 lung zones each.
Abnormal findings were detected in 97 (92%) participants,
with 80 (76%) having abnormal findings in bilateral lungs.
Confluent B-lines were the most common finding (92%) along
with a non-homogenous pleural line (78%). Lung consolidation
was observed in 57 patients (54%) with large consolidation in
33 (31%). Large consolidations were found mostly in the posterior bases (33 large consolidations in L6 or R6 out of 53 total
large consolidations). Discrete B-lines were seen in 17 patients
(16%), and discreet B-lines without any confluence was rare
(<1% of all images). The median number of lung zones with
abnormalities per patient was 6 (IQR, 3 to 9).
The median total lung ultrasound score was 12 (IQR, 6 to
18, max 25). Inter-rater reliability for the score was 0.95
(95% CI 0.94-0.97) with only 34 (2.7%) total disagreements
and only 0.55% (7/1260) scores changed before arriving at the

final consensus. The score distribution by zone is pictorially
displayed in Supplementary Figure 2.
Lung findings by clinical outcome. Multiple abnormalities were
over-represented in the predefined outcome groups except for
the outcome of death, which had no associations. A higher
total lung ultrasound score was associated with need for the
ICU (median total lung ultrasound 18 in the ICU group vs. 11
non-ICU group; p ¼ 0.004), a length of stay  9d (15 vs 10,
p ¼ 0.016) and a need for intensive respiratory support (18
vs. 8.5, P < 0.001, see Figure 2). A total lung ultrasound
score <5 had a negative predictive value of 100% for the need
of intensive respiratory support. Bilateral findings and any
large (>1 cm) confluent B-lines were also seen more frequently in these outcomes. Small consolidations were
over-represented in the length of stay  9d (p ¼ 0.006) and
intensive respiratory support groups (P ¼ 0.004), but not in
death or ICU groups. Surprisingly, large consolidations were
only over-represented in the intensive respiratory support
group (p ¼ 0.036), but not hospitalization duration  9d,
death, or ICU groups. The summary of findings by outcome
group is summarized in Table 2.
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Table 2. Lung Ultrasound Findings and Outcome in Hospitalized Patients Admitted With COVID-19.

All patients
n ¼ 105
Abnormal lung ultrasound
Distribution
Bilateral
Affected areas  6
 3 B lines
Any confluent B-line(s)
Small (<1 cm) confluence
Large (>1 cm) confluence
White lung
Non-homogenous pleural line
Any consolidation(s)
Small (< 1 cm)
Large (> 1 cm)
Total ultrasound score

Intensive
respiratory
support
n ¼ 33

Length of stay
9 days,
n ¼ 53

p - value

Length of stay
< 9 days,
n ¼ 52

0.054

60 (90)

37 (97)

0.253

p - value

97 (92)

64 (89)

33 (100)

80
56
17
97
46
92
40
82
57
45
33
12

47 (65)
31 (43)
7 (10)
64 (89)
35 (49)
59 (82)
21 (29)
54 (75)
32 (44)
24 (33)
18 (25)
8.5 (4, 15)

33 (100)
25 (76)
10 (30)
33 (100)
11 (33)
33 (100)
19 (58)
28 (85)
25 (76)
21 (64)
15 (45)
18 (11, 22)

<0.001
0.002
0.116
0.054
0.143
0.008
0.005
0.257
0.003
0.004
0.036
<0.001

47 (70)
30 (45)
8 (12)
60 (90)
35 (52)
56 (84)
21 (31)
50 (75)
32 (48)
22 (33)
21 (31)
10.0 (4, 18)

33 (87)
26 (68)
9 (24)
37 (97)
11 (29)
36 (95)
19 (50)
32 (84)
25 (66)
23 (61)
12 (32)
15.0 (8, 21)

0.054
0.020
0.116
0.253
0.021
0.127
0.059
0.254
0.075
0.006
0.980
0.016

Alive
n ¼ 96 (%)

Death
n ¼ 9 (%)

p – value

No ICU
(n ¼ 80)

ICU
(n ¼ 25)

p - value

(76)
(53)
(16)
(92)
(44)
(88)
(38)
(78)
(54)
(43)
(31)
(6, 18)

All patients
n ¼ 105 (%)
Abnormal lung ultrasound
Distribution
Bilateral
Affected areas  6
 3 B lines
Any confluent B-line(s)
Small (<1 cm) confluence
Large (>1 cm) confluence
White lung
Non-homogenous pleural
line
Any consolidation(s)
Small (< 1 cm)
Large (> 1 cm)
Total ultrasound score

Asymptomatic/
non-intensive
respiratory support
n ¼ 72

97 (92)

88 (92)

9 (100)

1.000

72 (90)

25 (100)

0.194

80 (76)
56 (53)

71 (74)
50 (52)

9 (100)
6 (67)

0.111
0.498

55 (69)
39 (49)

25 (100)
17 (68)

<0.001
0.092

97
46
92
40
82

(92)
(44)
(88)
(38)
(78)

88
42
83
35
75

(92)
(44)
(87)
(37)
(78)

9 (100)
4 (44)
9 (100)
5 (56)
7 (78)

1.000
1.000
0.597
0.297
1.000

72
37
67
25
62

(90)
(46)
(84)
(31)
(78)

25 (100)
9 (36)
25 (100)
15 (60)
20 (80)

0.194
0.367
0.035
0.010
0.792

57
45
33
12

(54)
(43)
(31)
(6, 18)

51
41
30
12

(53)
(43)
(31)
(5, 18)

6 (67)
4 (44)
3 (33)
18 (10, 19)

0.504
1.000
1.000
0.122

40
31
23
11

(50)
(39)
(29)
(4, 17)

17 (68)
14 (56)
10 (40)
18 (10, 22)

0.115
0.128
0.290
0.004

Values are N (%) or Median (IQR). Intensive respiratory support defined as high flow oxygen via nasal cannula, a non-rebreather mask, or mechanical ventilation.
*ICU care, mechanical ventilation, or death are not mutually exclusive.

Lung findings predicting clinical outcomes. The total lung ultrasound score ranged from 0 to 25 with each third of patients
having a total lung ultrasound of 0-7, 8-16 and 17-25, respectively. The total lung ultrasound 0-7 score group had a median
LOS of 4 days, the total lung ultrasound score 8-16 group
median was 5 days and the highest total lung ultrasound score
group 17-25 had a median hospital stay of 9 days. The total
lung ultrasound scores for the shortest two-thirds length of
stays (0-16 score) compared to upper third (17) was significantly different (p ¼ 0.002) and is illustrated in Figure 3.
Logistic regression models built using all twelve lung zones
could not predict any of the pre-specified outcomes; however,
models with a subset of zones were more predictive. The best
model using lung ultrasound scores included only 6 zones: L1,
R1, L3, R3, L6, and R6. This model did not well predict death
(AUC 0.69) or length of stay 9d (AUC 0.66). However, it
better predicted need for intensive respiratory support (AUC

0.76) or ICU need (AUC 0.81) and a negative prediction had a
NPV of 89% (95% CI 80-95%) for ICU need and 94% (95% CI
83-99%) for requiring intensive respiratory support Two zones
scores stood out as most predictive, L6 ¼ 3 and R1 2 for
respiratory support or ICU need, and predictive odds of each
were significant (P < 0.01).
Similarly, using individual findings from a more limited
4 zones (L1, R1, L6, and R6) had moderate predictability for
hospitalizations  9d (AUC 0.7), intensive respiratory support (AUC 0.77), or ICU (AUC 0.82) but not death (AUC
0.35). Similar to the lung ultrasound model, negative prediction had a NPV of 89% (95% CI 81-95%) for ICU need, 86%
for hospitalizations  9d (95% CI 71- 95%) and 88% (95%
CI 78-95%) for requiring intensive respiratory support.
Again, the R1 and L6 zones findings had significant odds
related to outcomes. Specifically, large consolidation in L6
had significant odds for predicting hospitalizations 9 days,
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Figure 3. Cumulative incidence of duration of length of stay by
total lung ultrasound score. Stratified by the lower 2/3 of total lung
ultrasound scores (<17) versus the upper 1/3 (17).

respiratory support, or ICU need. Confluence is what seemed
to matter in R1 with large confluence having significant odds of
respiratory support or ICU need (P > 0.01). Full logistic regression operating characteristics are shown in in supplementary
Tables S1.and S2, coefficients and odds are shown supplementary Tables S3.and S4 and an online calculator is available for
real-time predictions (http://goodybedside.com/pocus/
covidcalculator).
Other radiography. Chest radiographs were abnormal in 78%
(80/103). Of 23 participants with normal chest radiographs,
17 had abnormalities detected on lung ultrasound. The abnormalities discovered by ultrasound included confluent B-lines
(n ¼ 16), pleural irregularity (n ¼ 11), or small consolidations
(n ¼ 2). The negative predictive value of a normal chest radiograph was 26% (6/23) for not finding lung abnormalities
on ultrasound. Due to infection control considerations, only
14 participants had received CT of the chest.

Discussion
We conducted a prospective observational cohort study at
2 tertiary care hospitals in the United States on consecutive
patients with confirmed COVID-19 infection admitted to a
non-ICU hospital medicine service. We endeavored to describe
in detail the lung ultrasound findings in this cohort as well as
to determine if any of those findings are associated with or
predictive of predefined clinical outcomes.
Most of the patients (92%) had abnormal findings detected on
point-of-care ultrasound. Confluent B-lines, non-homogenous
pleural lines, consolidations, and bilateral involvement were
frequent findings in hospitalized patients with COVID-19, consistent with prior reports.10,15,16,25 While these findings are not
specific to COVID-19 pneumonia, these findings can aid in the
diagnosis of COVID-19 pneumonia when the clinical suspicion
is high.
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Large confluent B-lines, consolidations, bilateral involvement, and any abnormality in  6 areas were associated with
a longer hospitalization and need for intensive respiratory support. Large confluent B-lines and bilateral involvement were
also associated with ICU stay. Any confluent B-line in R1 had
increased odds for IRS and ICU need in our logistic regression
model. That anterior and upper zone findings were prognostic
is in line with the findings of Castelao16 and involvement of
upper lung zones on CT has been associated with worse clinical
outcome.26 But that our finding is limited to the right anterior
zone is difficult to explain physiologically and may be a
stochastic anomaly, despite our larger patient cohort.
That consolidation is a late COVID-19 finding has been
previously described7 but surprisingly large consolidations
were only statistically associated with the intensive respiratory support group, not length of stay, or death. We observed
large consolidations with nearly equal frequency at either
base (L6 and R6); however, only a large consolidation in L6
was prognostic, not one in R6. Large consolidations in L6
zone had significant odds for a longer hospitalization or need
for intensive respiratory support and ICU. Again, the unilateral nature of this finding is difficult to explain, but that these
outcome groups were not small (ICU n ¼ 25/105, respiratory
support 33/105, hospitalization 9d 38/105) and the result
was significant and tested on an independent subset of our
data is compelling. Given that large consolidation in R6 had
little influence on the outcome prediction (instead of relatively lesser influence) increases the suspicion that there may
be something to this unilateral observation. A similar observation was reported by Yu et al. looking at the prognostic
value of CT findings on admission. They described an
increased incidence of left lower lobe consolidation with
worse outcome, though the result was not statistically
significant.26
The lung ultrasound score has good reproducibility
(k ¼ 0.95). Previous studies on lung ultrasound reported that
higher scores were associated with need for high-flow nasal
cannula, continuous positive airway pressure, noninvasive
mechanical ventilation,16 hospitalization,15 intensive care
stay,14 mechanical ventilation and death.17 In our study, higher
total lung ultrasound scores were associated with need for
intensive respiratory support or ICU, and a total lung ultrasound score of 17 associated with a longer length of stay
(9 vs. 5 d, p ¼ 0.002). The ultrasound score in lung zones R1
and L6 was prognostic, with R1  2 and L6 ¼ 3 having significant odds for the need for intensive respiratory support or
ICU but not predictive of longer hospitalization or death. No
finding seemed to be associated with death though 9% mortality rate in a cohort of 105 patients may be too low to observe a
difference. Also, the deaths were sporadic, and cause of death
from COVID-19 is often not purely from respiratory complications, while lung ultrasound findings likely primarily relate to
respiratory status.
Our study has notable limitations. First, we excluded
patients who were unable to provide consent. Neurologic manifestations such as impaired consciousness are common in
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patients with severe COVID-19.27 Therefore, some patients
with more severe disease may have been excluded. Second,
we used a phased-array probe, which is commonly used in
hospital medicine to perform ultrasound examinations. Lung
ultrasound using a higher frequency probe (e.g., linear probe)
with shallower depth is likely more sensitive in detecting more
subtle pleural line abnormalities and smaller consolidations,
though it is possible it is too sensitive as Haaksma et al. previously demonstrated that the linear probe had worse agreement compared to a phased array probe. 28 Additionally,
examination using 2 different probes for lung ultrasound in
COVID-19 patients is not practical and may increase the examination time and the risk of exposure. Finally, we did not perform
serial ultrasounds. It is unclear if the change in total lung ultrasound scores over time may have better prognostic value.
In conclusion, most of the patients hospitalized with
COVID-19 had lung ultrasound abnormalities on admission
and a higher ultrasound score was associated with worse
clinical outcomes, longer LOS, but not with death.
Point-of-care ultrasound can aid in the risk stratification for
patients with COVID-19 admitted to internal medicine wards
in order to triage those at higher risk of needing further
supportive care or interventional therapy. Additionally, our
models appear to predict which patients will not have poor
outcomes, excluding death, but this needs to be prospectively
validated.
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